Publicações

Renal Outcomes of Agalsidase Beta Treatment for Fabry Disease: Role of Proteinuria and Timing of Treatment Initiation

AuthID
P-002-CG8

Author(s)

Warnock, DG

Ortiz, A

Mauer, M

Linthorst, GE

Oliveira, JP

Serra, AL

Marodi, L

Mignani, R

Vujkovac, B

Beitner Johnson, D

Lemay, R

Cole, JA

Svarstad, E

Waldek, S

Germain, DP

Wanner, C

Group Author(s)

Fabry Registry

Tipo de Documento

Article

Year published

2012

Publicado

in NEPHROLOGY DIALYSIS TRANSPLANTATION, ISSN: 0931-0509

Volume: 27, Número: 3, Páginas: 1042-1049 (8)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1093/ndt/gfr420

Pubmed: 21804088

SCOPUS: 2-s2.0-84861168490

Wos: WOS:000301907200030

Source Identifiers

ISSN: 0931-0509

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Renal Outcomes of Agalsidase Beta Treatment for Fabry Disease: Role of Proteinuria and Timing of Treatment Initiation

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Renal Outcomes of Agalsidase Beta Treatment for Fabry Disease: Role of Proteinuria and Timing of Treatment Initiation

Links Úteis

Ajuda